Event agenda
Tuesday, 17 September 2024
13:30 - 14:00
Registration and welcome coffee
14:00 - 14:05
Welcome by Flanders Vaccine
14:05 - 14:35
14:35 - 14:50
Cationic polymers as non-viral vectors - Richard Hoogenboom, University of Ghent
The development of next generation cationic polymers as non-viral gene delivery vectors will be discussed, going beyond L-PEI.
1 speaker
14:50 - 15:05
A COVID-19 mucosal vaccine formulation adjuvanted with Bacillus subtilis spores - University of Hasselt
The SARS-CoV-2 receptor-binding domain (RBD) coadministered with Bacillus subtilis spores through the nasal route induces robust humoral and cellular, both mucosal and systemic immune responses in mice.
1 speaker
15:05 - 15:20
Intradermal vaccination: our Belgian experience - Patrick Soentjens, Institute of Tropical Medicine (ITM)
We will highlight our experiences with different intradermal vaccine schedules against rabies, tick borne encephalitis, mpox and covid-19.
15:20 - 15:35
Short talks Academia Q&A
15:35 - 16:00
Coffee Break
16:00 - 16:10
Skin vaccination: challenges and opportunities – Vanessa Vankerckhoven, IDEVAX
Skin vaccination offers a promising avenue in vaccine delivery. The talk will provide insights into delivery methods, immune response, stability, scalability, and regulatory hurdles, as well as clinical data.
1 speaker
16:10 - 16:20
A reducible carbamate ionizable lipid library tailored towards intramuscular and systemic therapeutic applications – Bram Bogaert, ETHERNA
In this presentation, we report on the development of a novel series of ionizable lipids based on a reducible biscarbamate linker that are suited for multiple prophylactic and therapeutic applications.
1 speaker
16:20 - 16:30
Routes of administration: perspectives from the veterinary field – Dieter Vancraeynest, ZOETIS
The veterinary field is confronted with very diverse animal species and often needs to mass administer vaccines at low cost. This talk will cover various routes of administration – focusing on opportunities and challenges.
1 speaker
16:30 - 16:40
Plant-made edible vaccines: A new approach for oral immunization – Jeroen Hofenk, SWIFTPHARMA
The edible vaccine is a new development that allows the introduction of desired genes into plants. They offer many advantages such as ease of manufacture, storage, cost- effectiveness, and better accessibility and acceptability by people globally.
16:40 - 17:00
Short talks Companies Q&A
17:00 - 18:00
Networking reception
17:00 - 18:00
Meeting block
- Reception
Meeting duration:10 minute time slots